Results 161 to 170 of about 13,786 (251)
Navigating Oral Food Challenges in Clinical Trials to Keep the Science Moving Forward
ABSTRACT The oral food challenge (OFC) has long been the reference standard for food allergy diagnosis, as well as to confirm natural development of oral tolerance. The utilization of OFCs has significantly broadened from its role in defining disease to defining participant eligibility, individual allergen reactivity thresholds and treatment outcomes ...
Edwin H. Kim +10 more
wiley +1 more source
ABSTRACT Allergic diseases arise from aberrant immune recognition of otherwise harmless environmental proteins and are driven by epitope‐specific interactions between allergens and the adaptive immune system. Although component‐resolved diagnostics have improved molecular characterisation of sensitization, they remain limited to whole‐allergen ...
Mark Møiniche +11 more
wiley +1 more source
Improved Bat Algorithm Based on Multipopulation Strategy of Island Model for Solving Global Function Optimization Problem. [PDF]
Guo SS, Wang JS, Ma XX.
europepmc +1 more source
Abstract As students learn and practice new skills in university courses, their behaviour can change in response to competing demands and increasing content complexity. However, most metrics used to evaluate study behaviour focus on the number or sequence of activities rather than on the change of behaviour.
Oleksandra Poquet +2 more
wiley +1 more source
Reporting cell planning-based cellular mobility management using a Binary Artificial Bat algorithm. [PDF]
Swayamsiddha S +4 more
europepmc +1 more source
Summary Over the past decade, there has been a substantial increase in the diversity and number of therapeutic options for myeloproliferative neoplasms (MPNs). While many remain within the clinical trial arena, the clinician and patient community have seen more approvals reaching the clinic and a rethink on how best we should be approaching these ...
Trung Q. Ngo +3 more
wiley +1 more source
2D Tsallis Entropy for Image Segmentation Based on Modified Chaotic Bat Algorithm. [PDF]
Ye Z +5 more
europepmc +1 more source
Summary Ruxolitinib remains first‐line standard of care for symptomatic myelofibrosis, but resistance/intolerance develops in most patients. Three Janus kinase inhibitors (JAKis) have entered the post‐ruxolitinib space via distinct pivotal trials. We systematically searched prospective trials evaluating JAKi in refractory adults with myelofibrosis ...
Andrea Duminuco +8 more
wiley +1 more source
Dynamic Inertia Weight Binary Bat Algorithm with Neighborhood Search. [PDF]
Huang X, Zeng X, Han R.
europepmc +1 more source

